EP2094246

TAKEDA PHARMACEUTICAL COMPANY LIMITED
Application Number
EP07859925A
Filing Date
Dec 17, 2007
Status
Granted And Under Opposition
Feb 28, 2020
Grant Date
Apr 1, 2020
External Links
Slate, Register

Biblio Summary

The patent EP2094246B1 was granted on Apr 1, 2020 by Takeda Pharmaceutical Company Limited The patent is currently Granted And Under Opposition.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

INSTONE TERRY/ READ HOWARD GRAHAM/APPLEYARD LEES IP LLPDec 16, 2020WITHDRAWN

The table below shows the patents of Takeda Pharmaceutical Company Limited that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3370729Methods For The Identification, Evaluation And Treatment Of Patients Having Multiple MyelomaSep 27, 20231
EP3263110Solid PreparationMay 10, 20231
EP3518933Methods Of Treating Uterine Fibroids And EndometriosisMar 16, 20221